Developing personalized cell and gene therapies
Miltenyi Biomedicine is a newly established biopharmaceutical company that develops innovative cell and gene therapies. We are committed to bring cancer treatments and regenerative therapies to patients worldwide.Learn more about us
Patients are our focus. We commit to helping patients live longer and have a better quality of life. At the core of our decision-making – from technological developments to business – we ask ourselves a fundamental question: is this the right thing for the patients?
We provide evidence-based medicine. We commit to making sure all our actions are based on real life, true data, clear facts and figures. Transparency is key in all we do. Our decisions are based on the fact that we want to offer patients a better life.
Fairness at all levels. We commit to fostering fairness within our company at all levels, from each individual employee to our corporate values and operational choices. Fairness is an essential element that impacts the quality of life of our patients and society at large.
Making a positive impact on patients affected by difficult-to-treat diseases requires more than a simple drug prescription. That’s why we are actively creating or optimizing integrated product platforms that include cancer immunotherapy and regenerative medicine. We are committed to developing and providing innovative cures for a broad range of diseases and to improving our patients’ quality of life throughout their treatment.
We are currently focusing on difficult-to-treat hematological cancers using CAR T technology whilst exploring treatments for other diseases. Our goal is to increase the number of patients who can benefit from new cell and gene therapies by providing more effective cures and reducing the waiting time for treatment.